Recommendations for use of zoledronic acid (Z) for prevention and treatment of osteoporosis in men on androgen deprivation therapy (ADT) for prostate cancer (PC)

Androgen Deprivation ◽

Osteoporosis In Men ◽

Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy

The World Journal of Men s Health ◽

10.5534/wjmh.210061 ◽

2022 ◽

Vol 40 (1) ◽

pp. 74

Author(s):

Enrique Casado ◽

Angel Borque-Fernando ◽

Manuel Caamaño ◽

Jenaro Graña ◽

Jesús Muñoz-Rodríguez ◽

...

Keyword(s):

Prostate Cancer ◽

Fragility Fractures ◽

Androgen Deprivation ◽

Quality of care provided to prostate cancer patients for prevention and treatment of osteoporosis induced by androgen deprivation therapy: Results of a chart audit.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e16074 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e16074-e16074

Author(s):

Henriette Breunis ◽

Rehab Chahin ◽

Husayn Gulamhusein ◽

Shabbir M.H. Alibhai

Keyword(s):

Prostate Cancer ◽

Quality Of Care ◽

Cancer Patients ◽

Androgen Deprivation ◽

Chart Audit ◽

Quality of care provided to prostate cancer (PC) patients for prevention and treatment of osteoporosis induced by androgen deprivation therapy (ADT)

Supportive Care in Cancer ◽

10.1007/s00520-016-3320-1 ◽

2016 ◽

Vol 24 (11) ◽

pp. 4713-4720 ◽

Cited By ~ 1

Author(s):

Rehab Chahin ◽

Husayn Gulamhusein ◽

Henriette Breunis ◽

Shabbir M.H. Alibhai

Keyword(s):

Prostate Cancer ◽

Quality Of Care ◽

Androgen Deprivation ◽

ZOLEDRONIC ACID AS ADJUNCT TO ANDROGEN DEPRIVATION THERAPY REDUCES BONE LOSS IN MEN WITH PROSTATE CANCER

European Urology Supplements ◽

10.1016/s1569-9056(06)60146-2 ◽

2006 ◽

Vol 5 (2) ◽

pp. 57 ◽

Cited By ~ 4

Author(s):

R. Casey ◽

W. Love ◽

C. Mendoza ◽

D. Reymond ◽

M. Zarenda

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Androgen Deprivation

Re: Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

10.1097/01.ju.0000095103.00300.2a ◽

2003 ◽

Vol 170 (6) ◽

pp. 2392-2393 ◽

Cited By ~ 2

Author(s):

W. Reid Pitts

Keyword(s):

Prostate Cancer ◽

Randomized Controlled Trial ◽

Zoledronic Acid ◽

Bone Loss ◽

Controlled Trial ◽

Androgen Deprivation ◽

Prevent Bone Loss ◽

Randomized Controlled

Bisphosphonates to Prevent Osteoporosis in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Drugs & Aging ◽

10.2165/00002512-200320030-00002 ◽

2003 ◽

Vol 20 (3) ◽

pp. 175-183 ◽

Cited By ~ 34

Author(s):

Matthew R. Smith

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation ◽

Osteoporosis In Men

Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis

International Journal of Clinical Oncology ◽

10.1007/s10147-013-0604-z ◽

2013 ◽

Vol 19 (4) ◽

pp. 693-701 ◽

Cited By ~ 8

Author(s):

Masahiro Nozawa ◽

Takeshi Inagaki ◽

Kazuhiro Nagao ◽

Tsukasa Nishioka ◽

Takahiro Komura ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Bone Metastasis ◽

Phase Ii ◽

Phase Ii Trial ◽

Androgen Deprivation ◽

Treatment Naïve

Osteoporosis in Men Treated With Androgen Deprivation Therapy for Prostate Cancer

10.1097/00005392-200205000-00003 ◽

2002 ◽

pp. 1952-1956 ◽

Cited By ~ 4

Author(s):

ROBERT W. ROSS ◽

ERIC J. SMALL

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation ◽

Osteoporosis In Men

1017: Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen-Deprivation Therapy for Prostate Cancer

10.1016/s0022-5347(18)31245-x ◽

2007 ◽

Vol 177 (4S) ◽

pp. 336-336 ◽

Cited By ~ 1

Author(s):

Vivek K. Wadhwa ◽

Robin Weston ◽

Nigel J. Parr

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Bone Loss ◽

Androgen Deprivation

Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

10.1097/01.ju.0000063820.94994.95 ◽

2003 ◽

Vol 169 (6) ◽

pp. 2008-2012 ◽

Cited By ~ 453

Author(s):

MATTHEW R. SMITH ◽

JAMES EASTHAM ◽

DONALD M. GLEASON ◽

DANIEL SHASHA ◽

SIMON TCHEKMEDYIAN ◽

...

Keyword(s):

Prostate Cancer ◽

Randomized Controlled Trial ◽

Zoledronic Acid ◽

Bone Loss ◽

Controlled Trial ◽

Androgen Deprivation ◽

Prevent Bone Loss ◽

Randomized Controlled